Select Medical (NYSE: SEM) shareholders approve $3.9bn buyout as founder-led consortium nears takeover
Read More Technology Industry News Baseten is suddenly worth $13bn, but can AI inference deliver software margins? Baseten’s enormous Series F gives the artificial intelligence infrastructure company fresh capital to expand computing capacity as enterprises seek cheaper, controllable alternatives to closed-model providers. byPallavi MadhirajuJune 26, 2026